Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

Prognostic classification of endometrial cancer using a molecular approach based on a twelve-gene NGS panel.

López-Reig R, Fernández-Serra A, Romero I, Zorrero C, Illueca C, García-Casado Z, Poveda A, López-Guerrero JA.

Sci Rep. 2019 Dec 2;9(1):18093. doi: 10.1038/s41598-019-54624-x.

2.

Herpes simplex virus type 1 spread in oligodendrocytic cells is highly dependent on MAL proteolipid.

López-Guerrero JA, de la Nuez C, Praena B, Sánchez-León E, Krummenacher C, Bello-Morales R.

J Virol. 2019 Nov 20. pii: JVI.01739-19. doi: 10.1128/JVI.01739-19. [Epub ahead of print]

3.

Isolation/Analysis of Extracellular Microvesicles from HSV-1-Infected Cells.

Bello-Morales R, López-Guerrero JA.

Methods Mol Biol. 2020;2060:305-317. doi: 10.1007/978-1-4939-9814-2_17.

PMID:
31617186
4.

Clinical Infections by Herpesviruses in Patients Treated with Valproic Acid: A Nested Case-Control Study in the Spanish Primary Care Database, BIFAP.

Gil M, González-González R, Vázquez-Calvo A, Álvarez-Gutiérrez A, Martín-Acebes MA, Praena B, Bello-Morales R, Saiz JC, López-Guerrero JA, Tabarés E, Sobrino F.

J Clin Med. 2019 Sep 11;8(9). pii: E1442. doi: 10.3390/jcm8091442.

5.

The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group For Ovarian Cancer Research (GEICO).

Leskela S, Romero I, Cristobal E, Pérez-Mies B, Rosa-Rosa JM, Gutierrez-Pecharroman A, Santón A, Gonzalez BO, López-Reig R, Hardisson D, Vera-Sempere F, Illueca C, Vieites B, López-Guerrero JA, Palacios J, Poveda A.

Am J Surg Pathol. 2019 Sep 6. doi: 10.1097/PAS.0000000000001365. [Epub ahead of print]

PMID:
31498173
6.

Amidic derivatives of valproic acid, valpromide and valnoctamide, inhibit HSV-1 infection in oligodendrocytes.

Praena B, Bello-Morales R, de Castro F, López-Guerrero JA.

Antiviral Res. 2019 Aug;168:91-99. doi: 10.1016/j.antiviral.2019.05.006. Epub 2019 May 25.

7.

Metabolomics Contributions to the Discovery of Prostate Cancer Biomarkers.

Gómez-Cebrián N, Rojas-Benedicto A, Albors-Vaquer A, López-Guerrero JA, Pineda-Lucena A, Puchades-Carrasco L.

Metabolites. 2019 Mar 8;9(3). pii: E48. doi: 10.3390/metabo9030048. Review.

8.

Implementation of massive sequencing in the genetic diagnosis of hereditary cancer syndromes: diagnostic performance in the Hereditary Cancer Programme of the Valencia Community (FamCan-NGS).

Ramírez-Calvo M, García-Casado Z, Fernández-Serra A, de Juan I, Palanca S, Oltra S, Soto JL, Castillejo A, Barbera VM, Juan-Fita MJ, Segura Á, Chirivella I, Sánchez AB, Tena I, Chaparro C, Salas D, López-Guerrero JA.

Hered Cancer Clin Pract. 2019 Jan 18;17:3. doi: 10.1186/s13053-019-0104-x. eCollection 2019.

9.

Extracellular Vesicles in Herpes Viral Spread and Immune Evasion.

Bello-Morales R, López-Guerrero JA.

Front Microbiol. 2018 Oct 25;9:2572. doi: 10.3389/fmicb.2018.02572. eCollection 2018.

10.

Suitability of melanoma FFPE samples for NGS libraries: time and quality thresholds for downstream molecular tests.

Millán-Esteban D, Reyes-García D, García-Casado Z, Bañuls J, López-Guerrero JA, Requena C, Rodríguez-Hernández A, Traves V, Nagore E.

Biotechniques. 2018 Aug;65(2):79-85. doi: 10.2144/btn-2018-0016.

11.

Chemokine Expression Is Involved in the Vascular Neogenesis of Ewing Sarcoma: A Preliminary Analysis of the Early Stages of Angiogenesis in a Xenograft Model.

Giner F, López-Guerrero JA, Fernández-Serra A, Machado I, Mayordomo-Aranda E, Peydró-Olaya A, Llombart-Bosch A.

Pediatr Dev Pathol. 2019 Jan-Feb;22(1):30-39. doi: 10.1177/1093526618782497. Epub 2018 Jun 12.

PMID:
29895220
12.

Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patients.

Moura DS, Ramos R, Fernandez-Serra A, Serrano T, Cruz J, Alvarez-Alegret R, Ortiz-Duran R, Vicioso L, Gomez-Dorronsoro ML, Garcia Del Muro X, Martinez-Trufero J, Rubio-Casadevall J, Sevilla I, Lainez N, Gutierrez A, Serrano C, Lopez-Alvarez M, Hindi N, Taron M, López-Guerrero JA, Martin-Broto J.

Oncotarget. 2018 Apr 3;9(25):17576-17588. doi: 10.18632/oncotarget.24799. eCollection 2018 Apr 3.

13.

CDKN2A germline alterations in melanoma patients with personal or familial history of pancreatic cancer.

De Unamuno B, García-Casado Z, Bañuls J, Requena C, Lopez-Guerrero JA, Nagore E.

Melanoma Res. 2018 Jun;28(3):246-249. doi: 10.1097/CMR.0000000000000442.

PMID:
29543703
14.

Role of Microvesicles in the Spread of Herpes Simplex Virus 1 in Oligodendrocytic Cells.

Bello-Morales R, Praena B, de la Nuez C, Rejas MT, Guerra M, Galán-Ganga M, Izquierdo M, Calvo V, Krummenacher C, López-Guerrero JA.

J Virol. 2018 Apr 27;92(10). pii: e00088-18. doi: 10.1128/JVI.00088-18. Print 2018 May 15.

15.

Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT).

Machado I, López-Guerrero JA, Scotlandi K, Picci P, Llombart-Bosch A.

Virchows Arch. 2018 May;472(5):815-824. doi: 10.1007/s00428-018-2316-2. Epub 2018 Feb 14.

PMID:
29445891
16.

Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients.

Capoluongo E, Ellison G, López-Guerrero JA, Penault-Llorca F, Ligtenberg MJL, Banerjee S, Singer C, Friedman E, Markiefka B, Schirmacher P, Büttner R, van Asperen CJ, Ray-Coquard I, Endris V, Kamel-Reid S, Percival N, Bryce J, Röthlisberger B, Soong R, de Castro DG.

Semin Oncol. 2017 Jun;44(3):187-197. doi: 10.1053/j.seminoncol.2017.08.004. Epub 2017 Sep 15. Review.

17.

Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes.

Collado R, Puiggros A, López-Guerrero JA, Calasanz MJ, Larráyoz MJ, Ivars D, García-Casado Z, Abella E, Orero MT, Talavera E, Oliveira AC, Hernández-Rivas JM, Hernández-Sánchez M, Luño E, Valiente A, Grau J, Portal I, Gardella S, Salgado AC, Giménez MT, Ardanaz MT, Campeny A, Hernández JJ, Álvarez S, Espinet B, Carbonell F.

Cancer Lett. 2017 Nov 28;409:42-48. doi: 10.1016/j.canlet.2017.08.041. Epub 2017 Sep 6.

PMID:
28888994
18.

Phenotyping and susceptibility of established porcine cells lines to African Swine Fever Virus infection and viral production.

Sánchez EG, Riera E, Nogal M, Gallardo C, Fernández P, Bello-Morales R, López-Guerrero JA, Chitko-McKown CG, Richt JA, Revilla Y.

Sci Rep. 2017 Sep 4;7(1):10369. doi: 10.1038/s41598-017-09948-x.

19.

Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors.

Machado I, Yoshida A, López-Guerrero JA, Nieto MG, Navarro S, Picci P, Llombart-Bosch A.

Pathol Res Pract. 2017 Sep;213(9):1048-1053. doi: 10.1016/j.prp.2017.08.002. Epub 2017 Aug 25.

PMID:
28864350
20.

Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia.

Pérez-Rambla C, Puchades-Carrasco L, García-Flores M, Rubio-Briones J, López-Guerrero JA, Pineda-Lucena A.

Metabolomics. 2017;13(5):52. doi: 10.1007/s11306-017-1194-y. Epub 2017 Mar 9.

21.

Insulin-like growth factor 1 receptor affects the survival of primary prostate cancer patients depending on TMPRSS2-ERG status.

Mancarella C, Casanova-Salas I, Calatrava A, García-Flores M, Garofalo C, Grilli A, Rubio-Briones J, Scotlandi K, López-Guerrero JA.

BMC Cancer. 2017 May 25;17(1):367. doi: 10.1186/s12885-017-3356-8.

22.

Primary Cutaneous Leiomyosarcoma Arising in a Patient With Li-Fraumeni Syndrome: A Neoplasm With Unusual Histopathologic Features and Loss of Heterozygosity at TP53 Gene.

Sabater-Marco V, Ferrando-Roca F, Morera-Faet A, García-García JA, Bosch SB, López-Guerrero JA.

Am J Dermatopathol. 2018 Mar;40(3):225-227. doi: 10.1097/DAD.0000000000000919. No abstract available.

PMID:
28475508
23.

Subcutaneous dermatofibrosarcoma protuberans, a rare subtype with predilection for the head: A retrospective series of 18 cases.

Llombart B, Serra-Guillén C, Rubio L, Nagore E, Requena C, Traves V, Calomarde L, Bancalari B, López-Guerrero JA, Guillen-Barona C, Sanmartín O.

J Am Acad Dermatol. 2017 Sep;77(3):503-511.e1. doi: 10.1016/j.jaad.2017.02.046. Epub 2017 Apr 15.

PMID:
28420485
24.

High-risk gastrointestinal stromal tumour (GIST) and synovial sarcoma display similar angiogenic profiles: a nude mice xenograft study.

Giner F, Machado I, Lopez-Guerrero JA, Mayordomo-Aranda E, Llombart-Bosch A.

Ecancermedicalscience. 2017 Mar 9;11:726. doi: 10.3332/ecancer.2017.726. eCollection 2017.

25.

GEIS guidelines for gastrointestinal sarcomas (GIST).

Poveda A, García Del Muro X, López-Guerrero JA, Cubedo R, Martínez V, Romero I, Serrano C, Valverde C, Martín-Broto J; GEIS (Grupo Español de Investigación en Sarcomas/Spanish Group for Sarcoma Research).

Cancer Treat Rev. 2017 Apr;55:107-119. doi: 10.1016/j.ctrv.2016.11.011. Epub 2017 Mar 2. Review.

26.

PCA3 as a second-line biomarker in a prospective controlled randomized opportunistic prostate cancer screening programme.

Rubio-Briones J, Casanova J, Martínez F, Domínguez-Escrig JL, Fernández-Serra A, Dumont R, Ramírez-Backhaus M, Gómez-Ferrer A, Collado A, Rubio L, Molina A, Vanaclocha M, Sala D, Lopez-Guerrero JA.

Actas Urol Esp. 2017 Jun;41(5):300-308. doi: 10.1016/j.acuro.2016.10.008. Epub 2017 Mar 23. English, Spanish.

PMID:
28342633
27.

Expression profiles of angiogenesis in two high grade chondrosarcomas: A xenotransplant experience in nude mice.

Giner F, López-Guerrero JA, Machado I, García-Casado Z, Fernández-Serra A, Peydró-Olaya A, Llombart-Bosch A.

Histol Histopathol. 2017 Dec;32(12):1281-1291. doi: 10.14670/HH-11-880. Epub 2017 Feb 3.

PMID:
28155218
28.

Erratum to: Gastrointestinal stromal tumors (GISTs): SEAP-SEOM consensus on pathologic and molecular diagnosis.

Martin-Broto J, Martinez-Marín V, Serrano C, Hindi N, López-Guerrero JA, Biscuola M, Ramos-Asensio R, Vallejo-Benítez A, Marcilla-Plaza D, González-Cámpora R.

Clin Transl Oncol. 2017 May;19(5):650. doi: 10.1007/s12094-017-1619-0. No abstract available.

PMID:
28138952
29.

Gastrointestinal stromal tumors (GISTs): SEAP-SEOM consensus on pathologic and molecular diagnosis.

Martin-Broto J, Martinez-Marín V, Serrano C, Hindi N, López-Guerrero JA, Bisculoa M, Ramos-Asensio R, Vallejo-Benítez A, Marcilla-Plaza D, González-Cámpora R.

Clin Transl Oncol. 2017 May;19(5):536-545. doi: 10.1007/s12094-016-1581-2. Epub 2016 Dec 9. Erratum in: Clin Transl Oncol. 2017 May;19(5):650. Bisculoa M [added].

PMID:
27943096
30.

Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas.

González-Vela MDC, Curiel-Olmo S, Derdak S, Beltran S, Santibañez M, Martínez N, Castillo-Trujillo A, Gut M, Sánchez-Pacheco R, Almaraz C, Cereceda L, Llombart B, Agraz-Doblas A, Revert-Arce J, López Guerrero JA, Mollejo M, Marrón PI, Ortiz-Romero P, Fernandez-Cuesta L, Varela I, Gut I, Cerroni L, Piris MÁ, Vaqué JP.

J Invest Dermatol. 2017 Jan;137(1):197-206. doi: 10.1016/j.jid.2016.08.015. Epub 2016 Sep 1.

31.

A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer.

Halvorsen AR, Bjaanæs M, LeBlanc M, Holm AM, Bolstad N, Rubio L, Peñalver JC, Cervera J, Mojarrieta JC, López-Guerrero JA, Brustugun OT, Helland Å.

Oncotarget. 2016 Jun 14;7(24):37250-37259. doi: 10.18632/oncotarget.9363.

32.

A splice variant in the ACSL5 gene relates migraine with fatty acid activation in mitochondria.

Matesanz F, Fedetz M, Barrionuevo C, Karaky M, Catalá-Rabasa A, Potenciano V, Bello-Morales R, López-Guerrero JA, Alcina A.

Eur J Hum Genet. 2016 Nov;24(11):1572-1577. doi: 10.1038/ejhg.2016.54. Epub 2016 May 18.

33.

Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study.

Martin-Broto J, Pousa AL, de Las Peñas R, García Del Muro X, Gutierrez A, Martinez-Trufero J, Cruz J, Alvarez R, Cubedo R, Redondo A, Maurel J, Carrasco JA, López-Martin JA, Sala Á, Meana JA, Ramos R, Martinez-Serra J, Lopez-Guerrero JA, Sevilla I, Balaña C, Vaz Á, De Juan A, Alemany R, Poveda A.

J Clin Oncol. 2016 Jul 1;34(19):2294-302. doi: 10.1200/JCO.2015.65.3329. Epub 2016 May 16.

PMID:
27185843
34.

DNA Source Selection for Downstream Applications Based on DNA Quality Indicators Analysis.

Lucena-Aguilar G, Sánchez-López AM, Barberán-Aceituno C, Carrillo-Ávila JA, López-Guerrero JA, Aguilar-Quesada R.

Biopreserv Biobank. 2016 Aug;14(4):264-70. doi: 10.1089/bio.2015.0064. Epub 2016 May 9.

35.

Role of Proteolipid Protein in HSV-1 Entry in Oligodendrocytic Cells.

Bello-Morales R, Crespillo AJ, Praena B, Tabarés E, Revilla Y, García E, Fraile-Ramos A, Baron W, Krummenacher C, López-Guerrero JA.

PLoS One. 2016 Jan 25;11(1):e0147885. doi: 10.1371/journal.pone.0147885. eCollection 2016.

36.

Inhibition of herpes virus infection in oligodendrocyte cultured cells by valproic acid.

Crespillo AJ, Praena B, Bello-Morales R, Lerma L, Vázquez-Calvo A, Martín-Acebes MA, Tabarés E, Sobrino F, López-Guerrero JA.

Virus Res. 2016 Mar 2;214:71-9. doi: 10.1016/j.virusres.2016.01.009. Epub 2016 Jan 21.

PMID:
26805038
37.

Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancer.

Murria Estal R, Palanca Suela S, de Juan Jiménez I, Alenda Gonzalez C, Egoavil Rojas C, García-Casado Z, López Guerrero JA, Juan Fita MJ, Sánchez Heras AB, Segura Huerta Á, Santaballa Bertrán A, Chirivella González I, Llop García M, Pérez Simó G, Barragán González E, Bolufer Gilabert P.

Fam Cancer. 2016 Apr;15(2):193-200. doi: 10.1007/s10689-015-9864-2.

PMID:
26723934
38.

Frequent DPH3 promoter mutations in skin cancers.

Denisova E, Heidenreich B, Nagore E, Rachakonda PS, Hosen I, Akrap I, Traves V, García-Casado Z, López-Guerrero JA, Requena C, Sanmartin O, Serra-Guillén C, Llombart B, Guillén C, Ferrando J, Gimeno E, Nordheim A, Hemminki K, Kumar R.

Oncotarget. 2015 Nov 3;6(34):35922-30. doi: 10.18632/oncotarget.5771.

39.

Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy.

Rubio-Briones J, Borque A, Esteban LM, Casanova J, Fernandez-Serra A, Rubio L, Casanova-Salas I, Sanz G, Domínguez-Escrig J, Collado A, Gómez-Ferrer A, Iborra I, Ramírez-Backhaus M, Martínez F, Calatrava A, Lopez-Guerrero JA.

BMC Cancer. 2015 Sep 11;15:633. doi: 10.1186/s12885-015-1623-0.

40.

RG7112, a small-molecule inhibitor of MDM2, enhances trabectedin response in soft tissue sarcomas.

Obrador-Hevia A, Martinez-Font E, Felipe-Abrio I, Calabuig-Fariñas S, Serra-Sitjar M, López-Guerrero JA, Ramos R, Alemany R, Martín-Broto J.

Cancer Invest. 2015;33(9):440-50. doi: 10.3109/07357907.2015.1064534. Epub 2015 Aug 17.

PMID:
26288114
41.

RG7112, a Small-Molecule Inhibitor of MDM2, Enhances Trabectedin Response in Soft Tissue Sarcomas.

Obrador-Hevia A, Martinez-Font E, Felipe-Abrio I, Calabuig-Fariñas S, Serra-Sitjar M, López-Guerrero JA, Ramos R, Alemany R, Martín-Broto J.

Cancer Invest. 2015 Aug 17. [Epub ahead of print]

PMID:
26279182
42.

Optimizing sharing of hospital biobank samples.

Riegman PH, de Jong B, Daidone MG, Söderström T, Thompson J, Hall JA, Mendy M, Ten Hoeve J, Broeks A, Reed W, Morente MM, López-Guerrero JA, Collins VP, Rogan J, Ringborg U.

Sci Transl Med. 2015 Jul 22;7(297):297fs31. doi: 10.1126/scitranslmed.3009279.

PMID:
26203078
43.

The early stages of tumor angiogenesis in human osteosarcoma: a nude mice xenotransplant model.

Giner F, López-Guerrero JA, Machado I, García-Casado Z, Peydró-Olaya A, Llombart-Bosch A.

Virchows Arch. 2015 Aug;467(2):193-201. doi: 10.1007/s00428-015-1791-y. Epub 2015 Jun 9.

PMID:
26055533
44.

[Histological factors predicting loco-regional lymph node metastasis in early invasive colorectal adenocarcinoma pT1].

Machado I, Valera-Alberni M, Martínez de Juan F, López-Guerrero JA, García Fadrique A, Cruz J, Martínez Lapiedra C, de Alcantara FM, Yaya R, Campos J, Fernández-Martos C, Estevan R.

Gastroenterol Hepatol. 2016 Jan;39(1):1-8. doi: 10.1016/j.gastrohep.2015.04.006. Epub 2015 Jun 3. Spanish.

PMID:
26049903
45.

MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer.

Casanova-Salas I, Masiá E, Armiñán A, Calatrava A, Mancarella C, Rubio-Briones J, Scotlandi K, Vicent MJ, López-Guerrero JA.

PLoS One. 2015 May 13;10(5):e0125576. doi: 10.1371/journal.pone.0125576. eCollection 2015.

46.

[Update on the diagnosis of PCa in urine. The current role of urine markers].

Fernandez-Serra A, Casanova-Salas I, Rubio L, Calatrava A, García-Flores M, García-Casado Z, López-Guerrero JA, Rubio-Briones J.

Arch Esp Urol. 2015 Apr;68(3):240-9. Review. Spanish.

PMID:
25948797
47.

External validation of FXYD3 and KRT20 as predictive biomarkers for the presence of micrometastasis in muscle invasive bladder cancer lymph nodes.

Ramírez-Backhaus M, Fernández-Serra A, Rubio-Briones J, Cruz Garcia P, Calatrava A, Garcia Casado Z, Casanova Salas I, Rubio L, Solsona E, López-Guerrero JA.

Actas Urol Esp. 2015 Oct;39(8):473-81. doi: 10.1016/j.acuro.2015.02.002. Epub 2015 Apr 25. English, Spanish.

PMID:
25920992
48.

ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents.

Mancarella C, Casanova-Salas I, Calatrava A, Ventura S, Garofalo C, Rubio-Briones J, Magistroni V, Manara MC, López-Guerrero JA, Scotlandi K.

Oncotarget. 2015 Jun 30;6(18):16611-22.

49.

Report from the OECI Oncology Days 2014.

van Harten W, Stanta G, Bussolati G, Riegman P, Hoefler G, Becker K, Folprecht G, Truini M, Haybaeck J, Buiga R, Dono M, Bagg A, López Guerrero J, Zupo S, Lemare F, de Lorenzo F, Goedbloed N, Razavi D, Lövey J, Cadariu P, Rollandi G, Paparo F, Pierotti M, Ciuleanu T, De Paoli P, Weiner G, Saghatchian M, Lombardo C.

Ecancermedicalscience. 2014 Dec 31;8:496. doi: 10.3332/ecancer.2014.496. eCollection 2014.

50.

Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer.

López-Guerrero JA, Romero I, Poveda A.

Chin J Cancer. 2015 Jan;34(1):41-9. doi: 10.5732/cjc.014.10278. Review.

Supplemental Content

Loading ...
Support Center